Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Kiwi drug devastates COVID in the lab, team seeks funding for clinical trials
+News
Kiwi drug devastates COVID in the lab, team seeks funding for clinical trials
Friday 10 July 2020, 02:39 PM

The proposed COVID-19 drug would be inhaled using an inhaler like this
“The only question is if it’s going to cause side effects – hopefully not as it’s a humanised molecule, but you never know until you do trials”
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Iwanaga N, Cooper L, Rong L, et al. Novel ACE2-IgG1 fusions with improved activity against SARS-CoV2. bioRxiv preprint (online 15 June).
https://www.biorxiv.org/content/10.1101/2020.06.15.152157v1.full.pdf